Perils and Pitfalls in the Interpretation of Clinical Trials: A Reflection on the Recent Experience in Multiple Sclerosis

Publisher： Karger

E-ISSN： 1423-0208|18|2|53-63

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.18, Iss.2, 1999-02, pp. : 53-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advances in the Management of Multiple Sclerosis Spasticity: Recent Clinical Trials

By  

European Neurology, Vol. 72, Iss. 1, 2014-09 ,pp. : 9-11

Karger

Access to resources Recommend Favorite

Meta-Analysis of Clinical Trials with Copolymer 1 in Multiple Sclerosis

By  

European Neurology, Vol. 43, Iss. 4, 2000-05 ,pp. : 189-193

Karger

Access to resources Recommend Favorite

Neurosarcoidosis: Clinical Experience and Diagnostic Pitfalls

By  

European Neurology, Vol. 51, Iss. 2, 2004-03 ,pp. : 84-88

Karger

Access to resources Recommend Favorite

A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis

By  

Neuroepidemiology, Vol. 40, Iss. 3, 2012-12 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials

By  

Neuroepidemiology, Vol. 44, Iss. 1, 2015-01 ,pp. : 16-23

Karger

Access to resources Recommend Favorite